X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New poll of all 50 states and 435 Congressional Districts shows perils of so-called Medicare “negotiation”

By Cynthia Hicks  |    January 25, 2022
A new large-scale survey of 20,000 Americans covering all states and Congressional districts shows a majority find health care coverage costs unreasonable and a top priority health care issue for...   Read More

CBO reaffirms our innovation ecosystem leads to improved lives, long-term savings

By Brian Newell  |    January 21, 2022
The Congressional Budget Office (CBO) recently released a new report looking at trends in spending, prices and use of prescription drugs. While some politicians are trying to use the report to...   Read More

New study finds more than half of brand medicine spending goes to the supply chain and others

By Brian Newell  |    January 7, 2022
More than half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders in 2020 according to a new analysis from the Berkeley Research Group (BRG). These new...   Read More

New NHE data show the true picture of health care spending

By Katie Koziara  |    December 22, 2021
Last week, the Centers for Medicare & Medicaid Services (CMS) released National Health Expenditures (NHE) data that show net prices for retail prescription medicines declined, on average, by 0.1%...   Read More

3 things to know about the importance of post-approval research and development

By Andrew Powaleny  |    December 6, 2021
Despite tremendous progress and knowledge gained from post-approval R&D, some in Congress still fail to recognize innovation doesn’t stop at U.S. Food and Drug Administration (FDA) approval. After...   Read More

Guest post: Congress should not put future innovation at risk

By Guest Contributor  |    November 29, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

What is missing in the current drug pricing plan

By Brian Newell  |    November 23, 2021
A recent congressional forum looked at the role pharmacy benefit managers (PBMs) play in determining what patients pay out of pocket for prescription medicines. The forum provided an important...   Read More

ICYMI: PhRMA CEO speaks at STAT Summit about government price setting

By Andrew Powaleny  |    November 19, 2021
As part of the annual STAT Summit, PhRMA President and CEO Stephen J. Ubl recently spoke with STAT’s Matthew Herper to discuss the many unintended consequences expected from the latest drug...   Read More

In the current health care debate, Congress has lost sight of what matters to U.S. voters

By Debra DeShong  |    November 15, 2021
For months Congress has been debating massive changes to the nation’s social safety net, one of which is the highly popular Medicare prescription drug benefit. Unfortunately, much of what is being...   Read More

Ask About Adherence: CMS finds medication adherence saved Medicare up to $46.6B in avoided health care costs between 2013 and 2018

By Carolyn Ha  |    October 19, 2021
A recent Centers for Medicare & Medicaid Services (CMS) study found that medication use is improving among seniors and vulnerable beneficiary populations. Better adherence to medicines used to...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates